Incidence and risk factors of cerebral sinovenous thrombosis in infants.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
06 2021
Historique:
accepted: 15 12 2020
pubmed: 29 1 2021
medline: 24 9 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

To describe the incidence of term and preterm neonatal cerebral sinovenous thrombosis (CSVT) and identify perinatal risk factors. This was a national capture-recapture calculation-corrected surveillance and nested case-control study. Infants born preterm and at term with magnetic resonance imaging-confirmed neonatal CSVT were identified by surveillance in all paediatric hospitals in Germany (2015-2017). Incidence was corrected for underreporting using a capture-recapture method in one federal state and then extrapolated nationwide. We reviewed PubMed for comparisons with previously reported incidence estimators. We used a population-based perinatal database for quality assurance to select four controls per case and applied univariate and multivariable regression for risk factor analysis. Fifty-one newborn infants (34 males, 17 females; 14 born preterm) with neonatal CSVT were reported in the 3-year period. The incidence of term and preterm neonatal CSVT was 6.6 (95% confidence interval [CI] 4.4-8.7) per 100 000 live births. Median age at time of confirmation of the diagnosis was 9.95 days (range 0-39d). In the univariate analysis, male sex, preterm birth, hypoxia and related indicators (umbilical artery pH <7.1; 5-minute Apgar score <7; intubation/mask ventilation; perinatal asphyxia), operative vaginal delivery, emergency Caesarean section, and pathological fetal Doppler sonography were associated (p<0.05) with neonatal CSVT. Multivariable regression yielded hypoxia (odds ratio=20.3; 95% CI 8.1-50.8) as the independent risk factor. Incidence of neonatal CSVT was within the range of other population-based studies. The results suggest that hypoxia is an important perinatal risk factor for the aetiology of neonatal CSVT.

Identifiants

pubmed: 33506500
doi: 10.1111/dmcn.14816
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

697-704

Informations de copyright

© 2021 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.

Références

Shroff M, deVeber G. Sinovenous thrombosis in children. Neuroimaging Clin N America 2003; 13: 115-38.
Kersbergen KJ, Groenendaal F, Benders MJNL, de Vries LS. Neonatal cerebral sinovenous thrombosis: neuroimaging and long-term follow-up. J Child Neurol 2011; 26: 1111-20.
Ramenghi LA, Cardiello V, Rossi A. Neonatal cerebral sinovenous thrombosis. Handb Clin Neurol 2019; 162: 267-80.
Sébire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128: 477-89.
Fitzgerald KC, Williams LS, Garg BP, Carvalho KS, Golomb MR. Cerebral sinovenous thrombosis in the neonate. Arch Neurol 2006; 63: 405-9.
Kenet G, Waldman D, Lubetsky A, et al. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost 2004; 92: 713-8.
Berfelo FJ, Kersbergen KJ, van Ommen CHH, et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke 2010; 41: 1382-8.
Shevell MI, Silver K, O’Gorman AM, Watters GV, Montes JL. Neonatal dural sinus thrombosis. Pediatr Neurol 1989; 5: 161-5.
Wu YW, Miller SP, Chin K, et al. Multiple risk factors in neonatal sinovenous thrombosis. Neurology 2002; 59: 438-40.
deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
Chabrier S, Husson B, Dinomais M, Landrieu P, Nguyen The Tich S. New insights (and new interrogations) in perinatal arterial ischemic stroke. Thromb Res 2011; 127: 13-22.
Sorg A-L, von Kries R, Klemme M, et al. Risk factors for perinatal arterial ischaemic stroke: a large case-control study. Dev Med Child Neurol 2020; 62: 513-20.
Gerstl L, Weinberger R, Heinen F, et al. Arterial ischemic stroke in infants, children, and adolescents: results of a Germany-wide surveillance study 2015-2017. J Neurol 2019; 266: 2929-41.
Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995; 17: 243-64.
Federal Institute for Drugs and Medical Devices. ICD-10-GM [Internet]. Available at: URL: https://www.dimdi.de/dynamic/en/classifications/icd/icd-10-gm/ (accessed 6 January 2021).
Chapman DG. Some properties of the hypergeometric distribution with applications to zoological sample censuses. Berkeley, CA: University of California Press, 1951.
Statistisches Bundesamt (Destatis). Statistisches Bundesamt Deutschland. GENESIS-Online [Internet]. Available at: https://www-genesis.destatis.de/genesis/online;jsessionid=FFFD2C900F1350C21C97FB22F20A8991.tomcat_GO_1_3?operation=previous&levelindex=2&levelid=1534941870245&step=2 (accessed 6 January 2021).
Voigt M, Rochow N, Schneider KTM, et al. New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007-2011 from all 16 states of Germany [Article in German]. Z Geburtshilfe Neonatol 2014; 218: 210-7.
Grunt S, Mazenauer L, Buerki SE, et al. Incidence and outcomes of symptomatic neonatal arterial ischemic stroke. Pediatrics 2015; 135: e1220-e1228.
Tuckuviene R, Christensen AL, Helgestad J, Johnsen SP, Kristensen SR. Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994-2006: a nationwide population-based study. Acta Paediatr 2011; 100: 543-9.
Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003; 108: 1362-7.
Machado V, Pimentel S, Pinto F, Nona J. Perinatal ischemic stroke: a five-year retrospective study in a level-III maternity [Article in Portuguese]. Einstein (Sao Paulo) 2015; 13: 65-71.
Yang JYK, Chan AKC, Callen DJA, Paes BA. Neonatal cerebral sinovenous thrombosis: sifting the evidence for a diagnostic plan and treatment strategy. Pediatrics 2010; 126: e693-e700.
Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M. Gender does matter in perinatal medicine. Fetal Diagn Ther 2004; 19: 366-9.
Jordan LC, Rafay MF, Smith SE, et al. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr 2010; 156: 704-10.
Ramenghi LA, Govaert P, Fumagalli M, Bassi L, Mosca F. Neonatal cerebral sinovenous thrombosis. Semin Fetal Neonatal Med 2009; 14: 278-83.
Rutherford MA, Ramenghi LA, Cowan FM. Neonatal stroke. Arch Dis Child Fetal Neonatal Ed 2012; 97: F377-F384.
Hunt RW, Badawi N, Laing S, Lam A. Pre-eclampsia: a predisposing factor for neonatal venous sinus thrombosis? Pediatr Neurol 2001; 25: 242-6.
Raets MMA, Sol JJ, Govaert P, et al. Serial cranial US for detection of cerebral sinovenous thrombosis in preterm infants. Radiology 2013; 269: 879-86.
Carvalho KS, Bodensteiner JB, Connolly PJ, Garg BP. Cerebral venous thrombosis in children. J Child Neurol 2001; 16: 574-80.
Nwosu ME, Williams LS, Edwards-Brown M, Eckert GJ, Golomb MR. Neonatal sinovenous thrombosis: presentation and association with imaging. Pediatr Neurol 2008; 39: 155-61.

Auteurs

Anna-Lisa Sorg (AL)

Institute of Social Paediatrics and Adolescent Medicine, Division of Paediatric Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.

Rüdiger Von Kries (R)

Institute of Social Paediatrics and Adolescent Medicine, Division of Paediatric Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.

Mathias Klemme (M)

Department of Neonatology, University Children's Hospital and Perinatal Centre, Ludwig-Maximilians-University Munich, Munich, Germany.

Lucia Gerstl (L)

Department of Paediatric Neurology, University Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Andreas Beyerlein (A)

Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany.

Nicholas Lack (N)

Bavarian Quality Assurance for In-Patient Medical Care, Munich, Germany.

Ursula Felderhoff-Müser (U)

Department of Paediatrics I, Neonatology, University Duisburg-Essen, Essen, Germany.

Mark Dzietko (M)

Department of Paediatrics I, Neonatology, University Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH